Nature Medicine

Nature Medicine is an academic journal publishing research articles, reviews, news and commentaries in the biomedical area, including both basic research and early-phase clinical research. Topics covered include cancer, cardiovascular disease, gene therapy, immunology, vaccines, and neuroscience. The journal seeks to publish research papers that demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results. Founded in 1995, Nature Medicine is published by the Nature Publishing Group, a division of Macmillan Publishers Ltd, and is one of the rapidly expanding stable of Nature journals. As with other Nature journals, there is no external Editorial Board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. Nature Medicine is published monthly. Articles are archived online in text and PDF formats; access is by subscription only. Its 2010 impact factor was 25.430, making it the highest-cited research journal in preclinical medicine. It is also among the highest impact of primary (non-review) scientific journals.

Publisher
Nature Publishing Group
History
1995--present
Website
http://www.nature.com/nm/index.html
Impact factor
25.430 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Monkeypox found to be evolving at a faster rate than expected

A team of researchers at the National Institute of Health Doutor Ricardo Jorge in Portugal, working with a colleague at Lusófona University, also in Portugal, has found that the monkeypox virus has been evolving at a faster ...

Diseases, Conditions, Syndromes

First human challenge trial shows how COVID-19 strikes

A group of 36 volunteers have completed the first human challenge study of COVID-19, after being given the virus and then monitored to examine what happened to them after infection.

Diseases, Conditions, Syndromes

Persistent T cell response to omicron after infection and vaccination

The omicron variant can partly evade the antibody response provided by vaccination or infection with previous variants of SARS-CoV-2. However, T cells still recognize omicron, scientists at Karolinska Institutet in Sweden ...

Diseases, Conditions, Syndromes

Study looks at Moderna COVID-19 vaccine effectiveness

New Kaiser Permanente research published February 21, 2022 in Nature Medicine shows that while Moderna COVID-19 vaccine protection is strong against coronavirus infection by the Delta variant, it is not as strong against ...

Medical research

Melanoma breakthrough: New treatment saving lives

In what is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy, a new study has revealed that drug treatment before surgery is effective in preventing deadly spread of ...

page 1 from 40